Results 121 to 130 of about 103,858 (377)
The cost of blood in paediatric oncology patients [PDF]
, 2016 Introduction: Consumption of blood products is significant aiming to treat low cell counts and improve quality of life however 9% to 44% of the total consumption in centres abroad are unjustified.
Baldacchino, Ian +5 more
core
Platelet Transfusion Refractoriness
PlasmatologyPlatelet transfusion refractoriness (PTR) is a conditioikb1n where platelet counts fail to increase adequately in several transfusions, often found in hemato-oncological situations.
Anna Mira Lubis MD +2 more
doaj +1 more source
Pseudothrombocytopenia due to Phagocytosis of Platelets by Polymorphonuclear Leukocytes
American Journal of Hematology, EarlyView.
Iliana Stamatiou +4 more
wiley +1 more source
Drug Testing and Analysis, EarlyView.Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario Thevis +2 more
wiley +1 more source
Clinical efficiency of transfusion of pathogen-inactivated platelet concentrates
Терапевтический архив, 2013 AIM: To evaluate the effect of pathogen-inactivated platelet concentrates (PIPC) on posttransfusion platelet increments, hemorrhagic syndrome relief, and transfusion intervals/MATERIAL AND METHODS: This prospective study included 29 hemoblastosis ...
I M Nakastoev +9 more
doaj
Neonatal thrombocytopenia and platelets transfusion
Asian Journal of Transfusion Science, 2012 Background: Neonates often develop thrombocytopenia at some time during hospital stay. Platelet transfusion are frequently given to them and are likely to result in unnecessary transfusion.
Anil K Gupta +3 more
doaj +1 more source
ESC Heart Failure, EarlyView.Abstract Aims HeartMate 3 (HM3) left ventricular assist devices (LVADs) offer improved haemocompatibility‐related outcomes for end‐stage heart failure patients, facilitating the exploration of alternative anticoagulation therapies beyond warfarin.
Jennifer Jdaidani +7 more
wiley +1 more source
SAGE Open Medicine, 2020 Objective: We aimed to identify and represent factors associated with thrombocytopenia in intensive care unit, especially the pathogens and drugs related to severe and extremely thrombocytopenia.
Man-ka Zhang +11 more
doaj +1 more source
Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods [PDF]
, 2009 Whereas the reduction of transfusion related viral transmission has been a priority during the last decade, bacterial infection transmitted by transfusion still remains associated to a high morbidity and mortality, and constitutes the most frequent ...
Canellini, Giorgia +5 more
core +3 more sources
Current and novel biomarkers in cardiogenic shock
European Journal of Heart Failure, EarlyView.A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko +5 more
wiley +1 more source